Moderna Receives U.S. FDA Approval for Updated COVID-19 …
Sep 11, 2023 · Moderna's updated COVID-19 vaccine contains spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older. With the U.S. FDA's decision, Moderna will begin shipping doses to vaccination sites across the U.S., with updated vaccines expected to be available in the coming days.
Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine ...
Sep 6, 2023 · Clinical trial data from research assay confirmed Moderna's updated COVID-19 vaccine showed an 8.7 to 11-fold increase in neutralizing antibodies against circulating variants, including BA.2.86, EG.5, and FL.1.5.1 variants.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
FDA approved and authorized for emergency use updated mRNA COVID-19 vaccines (2024-2025 formula) to more closely target currently circulating variants to prevent COVID-19 and to provide...
Novavax COVID shots offer a third option, along with Pfizer and Moderna …
Aug 22, 2024 · The Food and Drug Administration has greenlighted three updated vaccines — the Pfizer-BioNTech and Moderna shots, and now a third one from Novavax, which was just authorized by the FDA on Friday.
Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine - Moderna
I am pleased to announce that the U.S. Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccine for this fall for individuals 12 years of age and older. The updated vaccine composition targets the KP.2 variant, based on guidance from the U.S. FDA.
News Details - Moderna
Mar 26, 2024 · The NEXTCove clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older in the United States, United Kingdom and Canada. mRNA-1283 was found to have a similar safety profile to Moderna's approved COVID-19 vaccines.
FDA Takes Action on Updated mRNA COVID-19 Vaccines to …
FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious ...
US FDA authorizes Pfizer-BioNTech and Moderna's updated COVID …
Sep 11, 2023 · The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer /BioNTech and Moderna that target a recently circulating Omicron variant of the...
The Moderna COVID-19 (mRNA-1273) vaccine: what you need …
Aug 18, 2022 · The Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.
FDA approves COVID shots from Moderna and Pfizer : Shots - Health News ...
Sep 11, 2023 · The vaccines from Moderna and Pfizer and its partner BioNTech were approved Monday for people 12 and older and under an emergency use authorization for children ages 6 months to 11 years old.